accession stringclasses 716
values | cik stringclasses 420
values | company stringclasses 422
values | ticker stringclasses 394
values | filed_date stringdate 2026-07-21 00:00:00 2026-10-19 00:00:00 ⌀ | form stringclasses 1
value | signal stringclasses 12
values | negative bool 2
classes | file_name stringclasses 691
values | url stringlengths 44 98 |
|---|---|---|---|---|---|---|---|---|---|
0001827635-26-000036 | 1827635 | Veradermics, Inc | MANE | 2026-10-19 | 8-K | topline | false | exhibit991datarelease101926.htm | https://www.sec.gov/Archives/edgar/data/1827635/000182763526000036/exhibit991datarelease101926.htm |
0001827635-26-000036 | 1827635 | Veradermics, Inc | MANE | 2026-10-19 | 8-K | ind | false | a304acallslidesfinal130a.htm | https://www.sec.gov/Archives/edgar/data/1827635/000182763526000036/a304acallslidesfinal130a.htm |
0001193125-26-424695 | 1479615 | Silence Therapeutics plc | null | 2026-10-19 | 8-K | clinical_hold | true | d172259dex21.htm | https://www.sec.gov/Archives/edgar/data/1479615/000119312526424695/d172259dex21.htm |
0001213900-26-110497 | 1795091 | OS Therapies Inc | OSTX | 2026-10-19 | 8-K | fast_track | false | ea030859901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1795091/000121390026110497/ea030859901ex99-1.htm |
0001213900-26-110497 | 1795091 | OS Therapies Inc | OSTX | 2026-10-19 | 8-K | orphan | false | ea030859901ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1795091/000121390026110497/ea030859901ex99-1.htm |
0001193125-26-424731 | 1662774 | IRulya Therapeutics Inc. | null | 2026-10-19 | 8-K | orphan | false | d123526dex991.htm | https://www.sec.gov/Archives/edgar/data/1662774/000119312526424731/d123526dex991.htm |
0001193125-26-424644 | 1314102 | EyePoint, Inc. | EYPT | 2026-10-19 | 8-K | topline | false | eypt-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526424644/eypt-ex99_2.htm |
0001193125-26-424755 | 1314102 | EyePoint, Inc. | EYPT | 2026-10-19 | 8-K | topline | false | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526424755/eypt-ex99_1.htm |
0001193125-26-424644 | 1314102 | EyePoint, Inc. | EYPT | 2026-10-19 | 8-K | endpoint_met | false | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526424644/eypt-ex99_1.htm |
0001193125-26-424644 | 1314102 | EyePoint, Inc. | EYPT | 2026-10-19 | 8-K | endpoint_missed | true | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526424644/eypt-ex99_1.htm |
0001193125-26-424755 | 1314102 | EyePoint, Inc. | EYPT | 2026-10-19 | 8-K | endpoint_missed | true | eypt-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1314102/000119312526424755/eypt-ex99_1.htm |
0001104659-26-116748 | 1818844 | Dogwood Therapeutics, Inc. | DWTX | 2026-10-19 | 8-K | topline | false | dwtx-ex99d1.htm | https://www.sec.gov/Archives/edgar/data/1818844/000110465926116748/dwtx-ex99d1.htm |
0001104659-26-116748 | 1818844 | Dogwood Therapeutics, Inc. | DWTX | 2026-10-19 | 8-K | fast_track | false | dwtx-ex99d1.htm | https://www.sec.gov/Archives/edgar/data/1818844/000110465926116748/dwtx-ex99d1.htm |
0001193125-26-424649 | 1816736 | Disc Medicine, Inc. | IRON | 2026-10-19 | 8-K | topline | false | d156263dex992.htm | https://www.sec.gov/Archives/edgar/data/1816736/000119312526424649/d156263dex992.htm |
0001213900-26-110477 | 1410098 | CorMedix Inc. | CRMD | 2026-10-19 | 8-K | topline | false | ea030895701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1410098/000121390026110477/ea030895701ex99-1.htm |
0001213900-26-110477 | 1410098 | CorMedix Inc. | CRMD | 2026-10-19 | 8-K | pdufa | false | ea030895701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1410098/000121390026110477/ea030895701ex99-1.htm |
0001104659-26-116910 | 1108205 | CURIS INC | CRIS | 2026-10-19 | 8-K | clinical_hold | true | tm2627615d1_ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1108205/000110465926116910/tm2627615d1_ex10-1.htm |
0001104659-26-116736 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-10-19 | 8-K | breakthrough | false | tm2627799d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926116736/tm2627799d1_ex99-1.htm |
0001104659-26-116736 | 1868279 | ArriVent BioPharma, Inc. | AVBP | 2026-10-19 | 8-K | orphan | false | tm2627799d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1868279/000110465926116736/tm2627799d1_ex99-1.htm |
0001193125-26-423377 | 1572616 | FRACTYL HEALTH, INC. | GUTS | 2026-10-16 | 8-K | topline | false | guts-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/1572616/000119312526423377/guts-ex99_2.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | topline | false | ex99-5.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-5.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | crl | true | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-1.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | clinical_hold | true | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-1.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | breakthrough | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-1.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | fast_track | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-1.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | orphan | false | ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-1.htm |
0001493152-26-047317 | 1716947 | Ensysce Biosciences, Inc. | ENSC | 2026-10-16 | 8-K | ind | false | ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1716947/000149315226047317/ex99-2.htm |
0001601830-26-000128 | 1601830 | RECURSION PHARMACEUTICALS, INC. | RXRX | 2026-10-15 | 8-K | topline | false | exhibit992-businessupdate.htm | https://www.sec.gov/Archives/edgar/data/1601830/000160183026000128/exhibit992-businessupdate.htm |
0001601830-26-000128 | 1601830 | RECURSION PHARMACEUTICALS, INC. | RXRX | 2026-10-15 | 8-K | discontinue | true | exhibit991-sanofipr.htm | https://www.sec.gov/Archives/edgar/data/1601830/000160183026000128/exhibit991-sanofipr.htm |
0001104659-26-115970 | 1372299 | Ocugen, Inc. | OCGN | 2026-10-15 | 8-K | topline | false | tm2627592d2_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926115970/tm2627592d2_ex99-1.htm |
0001104659-26-115921 | 1372299 | Ocugen, Inc. | OCGN | 2026-10-15 | 8-K | topline | false | tm2627592d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926115921/tm2627592d1_ex99-1.htm |
0001104659-26-115970 | 1372299 | Ocugen, Inc. | OCGN | 2026-10-15 | 8-K | interim | false | tm2627592d2_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926115970/tm2627592d2_ex99-1.htm |
0001104659-26-115970 | 1372299 | Ocugen, Inc. | OCGN | 2026-10-15 | 8-K | orphan | false | tm2627592d2_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1372299/000110465926115970/tm2627592d2_ex99-1.htm |
0001193125-26-422877 | 944809 | OPKO HEALTH, INC. | OPK | 2026-10-15 | 8-K | clinical_hold | true | opk-ex2_1.htm | https://www.sec.gov/Archives/edgar/data/944809/000119312526422877/opk-ex2_1.htm |
0001829126-26-011189 | 1979414 | NEONC TECHNOLOGIES HOLDINGS, INC. | NTHI | 2026-10-15 | 8-K | ind | false | neonctechnologies_ex99-2.htm | https://www.sec.gov/Archives/edgar/data/1979414/000182912626011189/neonctechnologies_ex99-2.htm |
0001213900-26-109587 | 1788028 | Jasper Therapeutics, Inc. | JSPR | 2026-10-15 | 8-K | topline | false | ea030865701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1788028/000121390026109587/ea030865701ex99-1.htm |
0001213900-26-109587 | 1788028 | Jasper Therapeutics, Inc. | JSPR | 2026-10-15 | 8-K | orphan | false | ea030865701ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1788028/000121390026109587/ea030865701ex99-1.htm |
0001193125-26-422929 | 2091349 | First Tracks Biotherapeutics, Inc. | TRAX | 2026-10-15 | 8-K | clinical_hold | true | trax-ex10_1.htm | https://www.sec.gov/Archives/edgar/data/2091349/000119312526422929/trax-ex10_1.htm |
0001171843-26-006647 | 1540159 | Edesa Biotech, Inc. | EDSA | 2026-10-15 | 8-K | topline | false | f8k_101426.htm | https://www.sec.gov/Archives/edgar/data/1540159/000117184326006647/f8k_101426.htm |
0001193125-26-422437 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-10-15 | 8-K | interim | false | crbp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/crbp-ex99_1.htm |
0001193125-26-422437 | 1595097 | Corbus Pharmaceuticals Holdings, Inc. | CRBP | 2026-10-15 | 8-K | fast_track | false | crbp-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1595097/000119312526422437/crbp-ex99_1.htm |
0001628280-26-066006 | 1253689 | CRESCENT BIOPHARMA, INC. | CBIO | 2026-10-15 | 8-K | ind | false | cbio-20261015.htm | https://www.sec.gov/Archives/edgar/data/1253689/000162828026066006/cbio-20261015.htm |
0001935979-26-000080 | 1935979 | Biohaven Ltd. | BHVN | 2026-10-15 | 8-K | ind | false | exhibit101-onoagreement.htm | https://www.sec.gov/Archives/edgar/data/1935979/000193597926000080/exhibit101-onoagreement.htm |
0001398733-26-000058 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-10-15 | 8-K | topline | false | a2026-10x19aquestivepduf.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000058/a2026-10x19aquestivepduf.htm |
0001398733-26-000058 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-10-15 | 8-K | crl | true | a2026-10x19aquestivepduf.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000058/a2026-10x19aquestivepduf.htm |
0001398733-26-000058 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-10-15 | 8-K | pdufa | false | a2026-10x19aquestivepduf.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000058/a2026-10x19aquestivepduf.htm |
0001731122-26-001348 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-10-15 | 8-K | orphan | false | e8009_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001348/e8009_ex99-1.htm |
0001731122-26-001348 | 1314052 | ANAVEX LIFE SCIENCES CORP. | AVXL | 2026-10-15 | 8-K | ind | false | e8009_8k.htm | https://www.sec.gov/Archives/edgar/data/1314052/000173112226001348/e8009_8k.htm |
0001104659-26-115687 | 1526119 | Verastem, Inc. | VSTM | 2026-10-14 | 8-K | topline | false | tm2627537d4_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926115687/tm2627537d4_ex99-3.htm |
0001104659-26-115687 | 1526119 | Verastem, Inc. | VSTM | 2026-10-14 | 8-K | breakthrough | false | tm2627537d4_ex99-3.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926115687/tm2627537d4_ex99-3.htm |
0001104659-26-115687 | 1526119 | Verastem, Inc. | VSTM | 2026-10-14 | 8-K | fast_track | false | tm2627537d4_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1526119/000110465926115687/tm2627537d4_ex99-1.htm |
0001104659-26-115874 | 1509261 | Rezolute, Inc. | RZLT | 2026-10-14 | 8-K | topline | false | tm2627620d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1509261/000110465926115874/tm2627620d1_ex99-1.htm |
0001104659-26-115709 | 1671502 | Quoin Pharmaceuticals Ltd. | QNRX | 2026-10-14 | 8-K | fast_track | false | tm2627548d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926115709/tm2627548d1_ex99-1.htm |
0001104659-26-115709 | 1671502 | Quoin Pharmaceuticals Ltd. | QNRX | 2026-10-14 | 8-K | orphan | false | tm2627548d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1671502/000110465926115709/tm2627548d1_ex99-1.htm |
0001129928-26-000072 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-10-14 | 8-K | fast_track | false | gobletc5pancanupdate.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000072/gobletc5pancanupdate.htm |
0001104659-26-115672 | 1819576 | Liquidia Corp | LQDA | 2026-10-14 | 8-K | fast_track | false | tm2627557d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1819576/000110465926115672/tm2627557d1_ex99-1.htm |
0001437749-26-032600 | 1710340 | Eton Pharmaceuticals, Inc. | ETON | 2026-10-14 | 8-K | orphan | false | ex_1025429.htm | https://www.sec.gov/Archives/edgar/data/1710340/000143774926032600/ex_1025429.htm |
0001437749-26-032600 | 1710340 | Eton Pharmaceuticals, Inc. | ETON | 2026-10-14 | 8-K | pdufa | false | ex_1025429.htm | https://www.sec.gov/Archives/edgar/data/1710340/000143774926032600/ex_1025429.htm |
0001689375-26-000057 | 1689375 | Entrada Therapeutics, Inc. | TRDA | 2026-10-14 | 8-K | topline | false | entradatherapeuticselevate.htm | https://www.sec.gov/Archives/edgar/data/1689375/000168937526000057/entradatherapeuticselevate.htm |
0001193125-26-421066 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-10-14 | 8-K | topline | false | d172621d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526421066/d172621d8k.htm |
0001193125-26-421066 | 1835022 | Coya Therapeutics, Inc. | COYA | 2026-10-14 | 8-K | fast_track | false | d172621d8k.htm | https://www.sec.gov/Archives/edgar/data/1835022/000119312526421066/d172621d8k.htm |
0001193125-26-420684 | 1840439 | Biomea Fusion, Inc. | BMEA | 2026-10-14 | 8-K | topline | false | d158362dex991.htm | https://www.sec.gov/Archives/edgar/data/1840439/000119312526420684/d158362dex991.htm |
0001398733-26-000056 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-10-14 | 8-K | orphan | false | etonaquestivelibervantpr.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000056/etonaquestivelibervantpr.htm |
0001398733-26-000056 | 1398733 | Aquestive Therapeutics, Inc. | AQST | 2026-10-14 | 8-K | pdufa | false | etonaquestivelibervantpr.htm | https://www.sec.gov/Archives/edgar/data/1398733/000139873326000056/etonaquestivelibervantpr.htm |
0001104659-26-115151 | 1953926 | Zenas BioPharma, Inc. | ZBIO | 2026-10-13 | 8-K | topline | false | tm2627406d1_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1953926/000110465926115151/tm2627406d1_ex99-1.htm |
0001819790-26-000069 | 1819790 | Tarsus Pharmaceuticals, Inc. | TARS | 2026-10-13 | 8-K | pdufa | false | exhibit992-alkeus63026co.htm | https://www.sec.gov/Archives/edgar/data/1819790/000181979026000069/exhibit992-alkeus63026co.htm |
0001193125-26-419769 | 1833214 | SAB Biotherapeutics, Inc. | null | 2026-10-13 | 8-K | topline | false | sabs-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1833214/000119312526419769/sabs-ex99_1.htm |
0001193125-26-419769 | 1833214 | SAB Biotherapeutics, Inc. | null | 2026-10-13 | 8-K | fast_track | false | sabs-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1833214/000119312526419769/sabs-ex99_1.htm |
0001129928-26-000070 | 1129928 | ONCOLYTICS BIOTECH INC | ONCY | 2026-10-13 | 8-K | fast_track | false | oncyipportfolioupdate.htm | https://www.sec.gov/Archives/edgar/data/1129928/000112992826000070/oncyipportfolioupdate.htm |
0001759425-26-000051 | 1759425 | Mirum Pharmaceuticals, Inc. | MIRM | 2026-10-13 | 8-K | topline | false | mirm-20261012.htm | https://www.sec.gov/Archives/edgar/data/1759425/000175942526000051/mirm-20261012.htm |
0001759425-26-000051 | 1759425 | Mirum Pharmaceuticals, Inc. | MIRM | 2026-10-13 | 8-K | endpoint_met | false | mirm-20261012.htm | https://www.sec.gov/Archives/edgar/data/1759425/000175942526000051/mirm-20261012.htm |
0001104659-26-115300 | 1638287 | MetaVia Inc. | MTVA | 2026-10-13 | 8-K | topline | false | mtva-ex99d1.htm | https://www.sec.gov/Archives/edgar/data/1638287/000110465926115300/mtva-ex99d1.htm |
0001929980-26-000542 | 1946021 | Horizon Space Acquisition I Corp. | null | 2026-10-13 | 8-K | clinical_hold | true | hspo_ex21.htm | https://www.sec.gov/Archives/edgar/data/1946021/000192998026000542/hspo_ex21.htm |
0001929980-26-000542 | 1946021 | Horizon Space Acquisition I Corp. | null | 2026-10-13 | 8-K | ind | false | hspo_ex21.htm | https://www.sec.gov/Archives/edgar/data/1946021/000192998026000542/hspo_ex21.htm |
0001193125-26-419761 | 2091349 | First Tracks Biotherapeutics, Inc. | TRAX | 2026-10-13 | 8-K | topline | false | trax-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/2091349/000119312526419761/trax-ex99_2.htm |
0001193125-26-419761 | 2091349 | First Tracks Biotherapeutics, Inc. | TRAX | 2026-10-13 | 8-K | fast_track | false | trax-ex99_2.htm | https://www.sec.gov/Archives/edgar/data/2091349/000119312526419761/trax-ex99_2.htm |
0001437749-26-032502 | 1053691 | CervoMed Inc. | CRVO | 2026-10-13 | 8-K | fast_track | false | ex_1024863.htm | https://www.sec.gov/Archives/edgar/data/1053691/000143774926032502/ex_1024863.htm |
0001437749-26-032502 | 1053691 | CervoMed Inc. | CRVO | 2026-10-13 | 8-K | orphan | false | ex_1024863.htm | https://www.sec.gov/Archives/edgar/data/1053691/000143774926032502/ex_1024863.htm |
0001140361-26-039334 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-10-13 | 8-K | endpoint_met | false | ef20083591_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126039334/ef20083591_ex99-1.htm |
0001140361-26-039334 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-10-13 | 8-K | breakthrough | false | ef20083591_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126039334/ef20083591_ex99-1.htm |
0001140361-26-039334 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-10-13 | 8-K | fast_track | false | ef20083591_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126039334/ef20083591_ex99-1.htm |
0001140361-26-039334 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-10-13 | 8-K | orphan | false | ef20083591_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126039334/ef20083591_ex99-1.htm |
0001140361-26-039334 | 1743881 | BridgeBio Pharma, Inc. | BBIO | 2026-10-13 | 8-K | pdufa | false | ef20083591_ex99-1.htm | https://www.sec.gov/Archives/edgar/data/1743881/000114036126039334/ef20083591_ex99-1.htm |
0001193125-26-419829 | 1107421 | Alaunos Therapeutics, Inc. | TCRT | 2026-10-13 | 8-K | clinical_hold | true | tcrt-ex10_1.htm | https://www.sec.gov/Archives/edgar/data/1107421/000119312526419829/tcrt-ex10_1.htm |
0001493152-26-046548 | 1712762 | bioAffinity Technologies, Inc. | null | 2026-10-09 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1712762/000149315226046548/ex10-1.htm |
0001193125-26-419174 | 1649094 | Vaxcyte, Inc. | PCVX | 2026-10-09 | 8-K | topline | false | d150490dex12.htm | https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/d150490dex12.htm |
0001193125-26-419174 | 1649094 | Vaxcyte, Inc. | PCVX | 2026-10-09 | 8-K | ind | false | d150490dex12.htm | https://www.sec.gov/Archives/edgar/data/1649094/000119312526419174/d150490dex12.htm |
0001683168-26-007758 | 1402328 | Sunshine Biopharma Inc. | null | 2026-10-09 | 8-K | clinical_hold | true | sunshine_ex1001.htm | https://www.sec.gov/Archives/edgar/data/1402328/000168316826007758/sunshine_ex1001.htm |
0001213900-26-108572 | 1734005 | Niki BioSolutions, Inc. | NIKI | 2026-10-09 | 8-K | clinical_hold | true | ea030826301ex1-1.htm | https://www.sec.gov/Archives/edgar/data/1734005/000121390026108572/ea030826301ex1-1.htm |
0001193125-26-418560 | 1488039 | ATOSSA THERAPEUTICS, INC. | ATOS | 2026-10-09 | 8-K | orphan | false | atos-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1488039/000119312526418560/atos-ex99_1.htm |
0001501697-26-000081 | 1501697 | X4 Pharmaceuticals, Inc | XFOR | 2026-10-08 | 8-K | topline | false | ex991pressreleasedatedocto.htm | https://www.sec.gov/Archives/edgar/data/1501697/000150169726000081/ex991pressreleasedatedocto.htm |
0001501697-26-000081 | 1501697 | X4 Pharmaceuticals, Inc | XFOR | 2026-10-08 | 8-K | fast_track | false | ex991pressreleasedatedocto.htm | https://www.sec.gov/Archives/edgar/data/1501697/000150169726000081/ex991pressreleasedatedocto.htm |
0001628280-26-065408 | 1706431 | Vir Biotechnology, Inc. | VIR | 2026-10-08 | 8-K | fast_track | false | a2026-10x01_8xkxvirx5500fa.htm | https://www.sec.gov/Archives/edgar/data/1706431/000162828026065408/a2026-10x01_8xkxvirx5500fa.htm |
0001193125-26-417939 | 34956 | TENAX THERAPEUTICS, INC. | TENX | 2026-10-08 | 8-K | endpoint_missed | true | d139658dex991.htm | https://www.sec.gov/Archives/edgar/data/34956/000119312526417939/d139658dex991.htm |
0001193125-26-417384 | 728387 | Perspective Therapeutics, Inc. | CATX | 2026-10-08 | 8-K | fast_track | false | catx-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/728387/000119312526417384/catx-ex99_1.htm |
0001193125-26-417402 | 2093101 | Atrium Therapeutics, Inc. | RNA | 2026-10-08 | 8-K | clinical_hold | true | d25901dex101.htm | https://www.sec.gov/Archives/edgar/data/2093101/000119312526417402/d25901dex101.htm |
0001193125-26-417935 | 1774857 | Aardvark Therapeutics, Inc. | AARD | 2026-10-08 | 8-K | clinical_hold | true | ck0001774857-ex99_1.htm | https://www.sec.gov/Archives/edgar/data/1774857/000119312526417935/ck0001774857-ex99_1.htm |
0001213900-26-107329 | 2023016 | Turn Therapeutics Inc. | TTRX | 2026-10-07 | 8-K | topline | false | ea030791101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/2023016/000121390026107329/ea030791101ex99-1.htm |
0001213900-26-107329 | 2023016 | Turn Therapeutics Inc. | TTRX | 2026-10-07 | 8-K | interim | false | ea030791101ex99-1.htm | https://www.sec.gov/Archives/edgar/data/2023016/000121390026107329/ea030791101ex99-1.htm |
0001493152-26-046085 | 1471727 | SRX Global Inc. | SRXH | 2026-10-07 | 8-K | clinical_hold | true | ex10-1.htm | https://www.sec.gov/Archives/edgar/data/1471727/000149315226046085/ex10-1.htm |
End of preview. Expand in Data Studio
No dataset card yet
- Downloads last month
- 44